Research programme: neuropeptide S receptor modulators - Pfizer

Drug Profile

Research programme: neuropeptide S receptor modulators - Pfizer

Alternative Names: WYE-198232

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Pfizer
  • Class Small molecules
  • Mechanism of Action Neuropeptide receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Anxiety disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Anxiety-disorders in USA
  • 07 Feb 2011 Early research in Anxiety disorders in USA (unspecified route)
  • 07 Feb 2011 Pharmacodynamics data from in vitro tests in Anxiety disorders presented at the 40th Annual Meeting of the Society for Neuroscience (SfN-2010)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top